Navigation Links
Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
Date:4/28/2008

Three Months Ended

March 31,

2008 2007

Operating activities:

Net income $31,945 $21,475

Adjustments to reconcile net income to net cash

provided by operating activities:

Depreciation and amortization 8,608 8,273

Amortization of premiums on investments, net of

accretion of discounts 1,735 1,052

Stock-based compensation charges 5,192 5,105

Stock option income tax benefits 369 58

Excess tax benefit from employee stock options (145) (1,284)

Gain on sale of stock holdings of Molecular

Profiling Institute, Inc. (1,600) -

Changes in assets and liabilities:

Accounts receivable 3,842 (2,649)

Inventories (1,796) (39)

Prepaid expenses 3,447 (2,478)

Other current assets (1,161) (1,354)

Other long term assets (743) (598)

Accounts payable 3,181 (1,549)

Accrued salaries and employee benefits (3,069) (891)

Other accrued expenses 965 (25)

Income tax payable 15,663 7,815

Deferred revenue (45) (330)

Deferred income tax 688 106

Deferred rent (10) (28)

D
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Gen-Probe to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
2. Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
3. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
4. Carl Hull Named President and Chief Operating Officer of Gen-Probe
5. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
6. Gen-Probe to Webcast Three Upcoming Presentations
7. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
8. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
9. Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
10. CV Therapeutics Reports 2008 First Quarter Financial Results
11. Caliper Life Sciences Reports West Coast Consolidation of Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... than electricity, to move data would consume much ... growing concern as chips, transistor counts rise. , ... light emitters, modulators, and detectors emitters ... source for optical chips is molybdenum disulfide (MoS2), ... a single, atom-thick layer. Other experimental on-chip light ...
(Date:9/19/2014)... 2014  An entire month is dedicated to one ... Charcot-Marie-Tooth disease (CMT) – a debilitating neuromuscular disease affecting ... atrophy, weakness, and foot and hand deformities. CMT affects ... CMT is a progressive disease, and over time patients ... devices such as leg braces, wheelchairs and scooters to ...
(Date:9/19/2014)... 2014  Nektar Therapeutics (NASDAQ: NKTR ... the analgesic profiles of a series of the ... molecules. The preclinical research candidates were created using ... The analgesic properties of kappa receptor agonism ... Kappa opioid receptors are expressed in the ...
(Date:9/19/2014)... Florida , September 19, 2014 ... release latest developments, patents and results of studies and ... Eli Lilly and Company (NYSE: LLY ), ... Corporation (NASDAQ: CELG ) and Arena Pharmaceuticals ... a leader in developing prodrug therapeutics for the treatment ...
Breaking Biology Technology:Toward optical chips 2Toward optical chips 3September is Charcot-Marie-Tooth (CMT) Awareness Month - Scheduled events, activities and important partnerships announced throughout the month! 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 4Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 3Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 6Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7
... YORK, March 16, 2011 Reportlinker.com announces that ... its catalogue: Global Growth ... http://www.reportlinker.com/p0397766/Global-Growth-Factors--Blood-And-Tissue--Industry.html ... Factors (Blood And Tissue) in US$ Million by ...
... Three scientists whose pioneering work in isolating human stem ... been named the recipients of the 11th annual Albany Medical ... Elaine Fuchs, Ph.D., the Rebecca C. Lancefield ... Development, and a Howard Hughes Medical Institute investigator at The ...
... SAN JOSE, Calif., March 16, 2011 Finesse ... measurement and control solutions for life sciences process ... processing platform for single-use bioreactors ranging from 25L ... turn-key control systems is designed to the highest ...
Cached Biology Technology:Global Growth Factors ( Blood And Tissue ) Industry 2Global Growth Factors ( Blood And Tissue ) Industry 3Global Growth Factors ( Blood And Tissue ) Industry 4Global Growth Factors ( Blood And Tissue ) Industry 5Global Growth Factors ( Blood And Tissue ) Industry 6Global Growth Factors ( Blood And Tissue ) Industry 7Global Growth Factors ( Blood And Tissue ) Industry 8Global Growth Factors ( Blood And Tissue ) Industry 9Global Growth Factors ( Blood And Tissue ) Industry 10Global Growth Factors ( Blood And Tissue ) Industry 11Global Growth Factors ( Blood And Tissue ) Industry 12Global Growth Factors ( Blood And Tissue ) Industry 13Global Growth Factors ( Blood And Tissue ) Industry 14Global Growth Factors ( Blood And Tissue ) Industry 15Global Growth Factors ( Blood And Tissue ) Industry 16Leaders in Stem Cell Research and Discovery to Share America's Most Distinguished Prize in Medicine 2Leaders in Stem Cell Research and Discovery to Share America's Most Distinguished Prize in Medicine 3Leaders in Stem Cell Research and Discovery to Share America's Most Distinguished Prize in Medicine 4Leaders in Stem Cell Research and Discovery to Share America's Most Distinguished Prize in Medicine 5Finesse Solutions Introduces New T700 cGMP Upstream Processing Platform Featuring G3 Hardware and Fully Integrated Single-Use Sensors 2
(Date:9/19/2014)... University of Oklahoma biology professor will study the unique ... that could eventually benefit people,s health. The OU ... the energy required to produce the signals used to ... electric signals at a rate of 500-600 discharges a ... for the electric fish are extreme, but necessary for ...
(Date:9/19/2014)... 2014 Nxt-ID, Inc. (Nasdaq: NXTD and ... the growing m-commerce market, updates the "Wocket in Your Pocket" celebrity ... and light middleweight weight classes, Vinny Pazienza (PAZ). ... Game of Thrones actor Ciaran Hinds and ... star Katey Sagal have been cast in Bleed ...
(Date:9/18/2014)... A sleep-promoting circuit located deep in the primitive brainstem ... by researchers at Harvard School of Medicine and the ... this is only the second "sleep node" identified in ... necessary and sufficient to produce deep sleep. , Published ... study demonstrates that fully half of all of the ...
Breaking Biology News(10 mins):NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 2NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 3No sedative necessary: Scientists discover new 'sleep node' in the brain 2
... human corneas restore transparency and don,t trigger a rejection ... hazy, according to experiments conducted in mice by researchers ... study will be published in the journal Stem ... suggest that cell-based therapies might be an effective way ...
... been widely regarded as contributing to autoimmune disease, but ... that low levels of vitamin D in patients with ... cause of disease and that supplementing with vitamin D ... team of researchers at the California-based non-profit Autoimmunity Research ...
... Engineers at Oregon State University have discovered a way to ... newest technologies for solar energy, in systems that may be ... The secret: diatoms. These tiny, single-celled marine life ... are the basis for much of the life in the ...
Cached Biology News:Stem cell therapy makes cloudy corneas clear, according to Pitt researchers 2Vitamin D may exacerbate autoimmune disease 2Ancient diatoms lead to new technology for solar energy 2
... for analytical performance , ... the ultimate in analytical,performance, the ... 810-MS features include: , ... providing reliable, routine, trace level,quantification. ...
... of urine will give a positive reaction for ... The Donors are of US origin and ... for HbsAg, HCV, HIV-1 & 2, Syphilis and ... MATERIAL IS SOLD FOR IN-VITRO DIAGNOSTIC USE ONLY ...
... OPTIMA is a fully automated microplate ... the widest possible range of applications ... gene assays luciferase, -galactosidase, gene activities ... dioxetanes..) Luminescent Immunoassays Cell-based ...
... dispensers save space and organize gloves, ... garb. They are the perfect benchtop ... in labs, processing and manufacturing. Clear ... the particles they attract. Open-slot design ...
Biology Products: